FreeStyle Libre Flash Glucose Monitoring System is FDA approved as a replacement for blood glucose monitoring.-Abbott.

Abbott announced that the FDA has approved the FreeStyle Libre Flash Glucose Monitoring System as a replacement for blood glucose monitoring (BGM) for adults with diabetes in the U.S. This revolutionary new glucose sensing technology eliminates the need for routine finger sticks and is the only personal continuous glucose monitor (CGM) that does not require finger stick calibration.

Designed to be approachable, accessible and affordable for the 30 million people with diabetes in America, the FreeStyle Libre system reads glucose levels through a sensor that is worn on the back of the upper arm for up to 10 days, making it the longest lasting personal glucose sensor available in the U.S.The BGM replacement indication means that people with diabetes and their physicians can now make treatment decisions based on information from the FreeStyle Libre system, without the need for painful routine finger sticks�and at a fraction of the cost of other CGM systems currently available.